219 related articles for article (PubMed ID: 37834383)
1. ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer.
Wee Y; Wang J; Wilson EC; Rich CP; Rogers A; Tong Z; DeGroot E; Gopal YNV; Davies MA; Ekiz HA; Tay JKH; Stubben C; Boucher KM; Oviedo JM; Fairfax KC; Williams MA; Holmen SL; Wolff RK; Grossmann AH
bioRxiv; 2023 Oct; ():. PubMed ID: 37873189
[TBL] [Abstract][Full Text] [Related]
2. ADP-Ribosylation Factor 6 Pathway Acts as a Key Executor of Mesenchymal Tumor Plasticity.
Hashimoto A; Hashimoto S
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834383
[TBL] [Abstract][Full Text] [Related]
3. ARF6 and AMAP1 are major targets of
Hashimoto S; Furukawa S; Hashimoto A; Tsutaho A; Fukao A; Sakamura Y; Parajuli G; Onodera Y; Otsuka Y; Handa H; Oikawa T; Hata S; Nishikawa Y; Mizukami Y; Kodama Y; Murakami M; Fujiwara T; Hirano S; Sabe H
Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17450-17459. PubMed ID: 31399545
[TBL] [Abstract][Full Text] [Related]
4. High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer.
Tsutaho A; Hashimoto A; Hashimoto S; Hata S; Kachi S; Hirano S; Sabe H
Cell Commun Signal; 2020 Jun; 18(1):101. PubMed ID: 32580737
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer.
Hashimoto A; Handa H; Hata S; Tsutaho A; Yoshida T; Hirano S; Hashimoto S; Sabe H
Cell Commun Signal; 2021 May; 19(1):54. PubMed ID: 34001163
[TBL] [Abstract][Full Text] [Related]
6. KRAS, MYC, and ARF6: inseparable relationships cooperatively promote cancer malignancy and immune evasion.
Sabe H
Cell Commun Signal; 2023 May; 21(1):106. PubMed ID: 37158894
[TBL] [Abstract][Full Text] [Related]
7. Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis.
Zhou W; Liu H; Yuan Z; Zundell J; Towers M; Lin J; Lombardi S; Nie H; Murphy B; Yang T; Wang C; Liao L; Goldman AR; Kannan T; Kossenkov AV; Drapkin R; Montaner LJ; Claiborne DT; Zhang N; Wu S; Zhang R
Cancer Cell; 2023 Apr; 41(4):740-756.e10. PubMed ID: 36963401
[TBL] [Abstract][Full Text] [Related]
8. Spatial biology of cancer evolution.
Seferbekova Z; Lomakin A; Yates LR; Gerstung M
Nat Rev Genet; 2023 May; 24(5):295-313. PubMed ID: 36494509
[TBL] [Abstract][Full Text] [Related]
9. Orchestration of mesenchymal plasticity and immune evasiveness
Hashimoto A; Handa H; Hata S; Hashimoto S
Front Oncol; 2022; 12():1005566. PubMed ID: 36408139
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 in cancer: from molecular mechanism to therapeutic modulation.
Chen X; Zhang T; Su W; Dou Z; Zhao D; Jin X; Lei H; Wang J; Xie X; Cheng B; Li Q; Zhang H; Di C
Cell Death Dis; 2022 Nov; 13(11):974. PubMed ID: 36400749
[TBL] [Abstract][Full Text] [Related]
11. The current state of the art and future trends in RAS-targeted cancer therapies.
Punekar SR; Velcheti V; Neel BG; Wong KK
Nat Rev Clin Oncol; 2022 Oct; 19(10):637-655. PubMed ID: 36028717
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammatory disease disrupts the blood-CNS barrier via crosstalk between proinflammatory and endothelial-to-mesenchymal-transition signaling.
Sun Z; Zhao H; Fang D; Davis CT; Shi DS; Lei K; Rich BE; Winter JM; Guo L; Sorensen LK; Pryor RJ; Zhu N; Lu S; Dickey LL; Doty DJ; Tong Z; Thomas KR; Mueller AL; Grossmann AH; Zhang B; Lane TE; Fujinami RS; Odelberg SJ; Zhu W
Neuron; 2022 Oct; 110(19):3106-3120.e7. PubMed ID: 35961320
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
